0001669191-22-000553.txt : 20220511 0001669191-22-000553.hdr.sgml : 20220511 20220511152431 ACCESSION NUMBER: 0001669191-22-000553 CONFORMED SUBMISSION TYPE: C-U PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20220511 DATE AS OF CHANGE: 20220511 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bioverge, Inc. CENTRAL INDEX KEY: 0001828649 IRS NUMBER: 822592905 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: C-U SEC ACT: 1933 Act SEC FILE NUMBER: 020-27997 FILM NUMBER: 22913376 BUSINESS ADDRESS: STREET 1: 237 KEARNY STREET #9171 CITY: SAN FRANCISCO STATE: CA ZIP: 94108 BUSINESS PHONE: 8664151001 MAIL ADDRESS: STREET 1: 237 KEARNY STREET STREET 2: STE. 9171 CITY: SAN FRANCISCO STATE: CA ZIP: 94108 C-U 1 primary_doc.xml C-U 0001828649 XXXXXXXX 020-27997 LIVE false true false End of offering. Issuer closed its offering with estimated gross proceeds of $744,806. The foregoing is in regard only to the amount raised under the Section 4(a)(6) exemption. Bioverge, Inc. Corporation DE 08-17-2017 237 Kearny Street Ste. 9171 San Francisco CA 94108 https://bioverge.com/ N NetCapital Funding Portal Inc. 0001669191 007-00035 283596 Up to 4.9% of amount raised for a successful offering None. Common Stock 5848 1.71000 We utilized three valuation methodologies: discounted cash flow, sum -of-the-parts, and comparable company analysis. 10000.08 Y First-come, first-served basis 1069998.30 03-01-2022 2 975622.00 544624.00 570343.00 266383.00 7034.00 4997.00 123702.00 123702.00 1363520.00 588520.00 68795.00 24047.00 0.00 0.00 0.00 0.00 -432913.00 -161357.00 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY B5 GU 1V PR VI Bioverge, Inc. Neil Littman Principal Executive Officer Neil Littman Principal Executive Officer 05-11-2022 Neil Littman Principal Financial Officer 05-11-2022 Neil Littman Principal Accounting Officer 05-11-2022 Neil Littman Board Member 05-11-2022